These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 19111019)

  • 1. Liver stem cells and hepatocellular carcinoma.
    Mishra L; Banker T; Murray J; Byers S; Thenappan A; He AR; Shetty K; Johnson L; Reddy EP
    Hepatology; 2009 Jan; 49(1):318-29. PubMed ID: 19111019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells and hepatocellular carcinoma.
    Yao Z; Mishra L
    Cancer Biol Ther; 2009 Sep; 8(18):1691-8. PubMed ID: 19901516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
    Marquardt JU; Factor VM; Thorgeirsson SS
    J Hepatol; 2010 Sep; 53(3):568-77. PubMed ID: 20646772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.
    Majumdar A; Curley SA; Wu X; Brown P; Hwang JP; Shetty K; Yao ZX; He AR; Li S; Katz L; Farci P; Mishra L
    Nat Rev Gastroenterol Hepatol; 2012 Sep; 9(9):530-8. PubMed ID: 22710573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical potential differentiation of liver cancer stem cells.
    Zhang W; Mu D; Feng K
    Adv Clin Exp Med; 2017 Oct; 26(7):1137-1141. PubMed ID: 29211363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].
    Shimizu T; Nakagawa K
    Nihon Rinsho; 2015 Aug; 73(8):1342-8. PubMed ID: 26281688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental signaling pathways in brain tumor-derived stem-like cells.
    Clark PA; Treisman DM; Ebben J; Kuo JS
    Dev Dyn; 2007 Dec; 236(12):3297-308. PubMed ID: 18000980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating pancreatic beta-cells from embryonic stem cells by manipulating signaling pathways.
    Champeris Tsaniras S; Jones PM
    J Endocrinol; 2010 Jul; 206(1):13-26. PubMed ID: 20385725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.
    Coulouarn C; Cavard C; Rubbia-Brandt L; Audebourg A; Dumont F; Jacques S; Just PA; Clément B; Gilgenkrantz H; Perret C; Terris B
    Carcinogenesis; 2012 Sep; 33(9):1791-6. PubMed ID: 22696594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
    Li M; Mu XD; Song JR; Zhai PT; Cheng Y; Le Y; Li ZB
    Cell Cycle; 2021 May; 20(10):1010-1020. PubMed ID: 33970778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
    Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling.
    Wu J; Zhu P; Lu T; Du Y; Wang Y; He L; Ye B; Liu B; Yang L; Wang J; Gu Y; Lan J; Hao Y; He L; Fan Z
    J Hepatol; 2019 May; 70(5):918-929. PubMed ID: 30582981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Wnt/β-catenin and Notch signalling in the activated canine hepatic progenitor cell niche.
    Schotanus BA; Kruitwagen HS; van den Ingh TS; van Wolferen ME; Rothuizen J; Penning LC; Spee B
    BMC Vet Res; 2014 Dec; 10():309. PubMed ID: 25551829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
    Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
    Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
    Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Road to stemness in hepatocellular carcinoma.
    Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
    World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma.
    Pang RW; Poon RT
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1081-94. PubMed ID: 22873219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.